1. Agonistic anti‐CD27 antibody ameliorates EAE by suppressing IL‐17 production. Issue 10 (15th August 2022) Authors: Vogel, Isabel; Acolty, Valerie; Keler, Tibor; Goriely, Stanislas; Leo, Oberdan; Moser, Muriel Journal: European journal of immunology Issue: Volume 52:Issue 10(2022) Page Start: 1620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis. (March 2018) Authors: Nicol, Bryan; Salou, Marion; Vogel, Isabel; Garcia, Alexandra; Dugast, Emilie; Morille, Jeremy; Kilens, Stéphanie; Charpentier, Eric; Donnart, Audrey; Nedellec, Steven; Jacq-Foucher, Marylène; Le Frère, Fabienne; Wiertlewski, Sandrine; Bourreille, Arnaud; Brouard, Sophie; Michel, Laure; David, La... Journal: Journal of autoimmunity Issue: Volume 88(2018) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CD28/CTLA‐4/B7 costimulatory pathway blockade affects regulatory T‐cell function in autoimmunity. Issue 6 (3rd April 2015) Authors: Vogel, Isabel; Kasran, Ahmad; Cremer, Jonathan; Kim, Yoo‐Jin; Boon, Louis; Van Gool, Stefaan W.; Ceuppens, Jan L. Journal: European journal of immunology Issue: Volume 45:Issue 6(2015:Jun.) Page Start: 1832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of the Global Challenges Research Fund. Synthesis Report of evidence on integration of relevance, fairness, gender, poverty and social inclusion in funded activities. Stage 1a, (2022) Other Names: Vogel, Isabel; Sword-Daniels, Victoria; Guthrie, Susan; ITAD Ltd.; RAND Europe.; Great Britain., Department for Business, Energy & Industrial Strategy. Record Type: Book Extent: 1 online resource
5. Foxp3+ regulatory T cells are activated in spite of B7‐CD28 and CD40‐CD40L blockade. Issue 4 (22nd February 2013) Authors: Vogel, Isabel; Verbinnen, Bert; Maes, Wim; Boon, Louis; Van Gool, Stefaan W.; Ceuppens, Jan L. Journal: European journal of immunology Issue: Volume 43:Issue 4(2013:Apr.) Page Start: 1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Keeping it Real: Using Mechanisms to Promote Use in the Realist Evaluation of the Building Capacity to Use Research Evidence Program. Issue 167 (6th October 2020) Authors: Punton, Melanie; Vogel, Isabel Editors: Schmitt, Johannes Journal: New directions for evaluation Issue: Issue 167(2020) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Protein aggregation as an antibiotic design strategy. Issue 5 (9th December 2015) Authors: Bednarska, Natalia G.; van Eldere, Johan; Gallardo, Rodrigo; Ganesan, Ashok; Ramakers, Meine; Vogel, Isabel; Baatsen, Pieter; Staes, An; Goethals, Marc; Hammarström, Per; Nilsson, K. Peter R.; Gevaert, Kris; Schymkowitz, Joost; Rousseau, Frederic Journal: Molecular microbiology Issue: Volume 99:Issue 5(2016) Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Regulatory T cells constrain the TCR repertoire of antigen‐stimulated conventional CD4 T cells. (20th December 2017) Authors: Fontaine, Martina; Vogel, Isabel; Van Eycke, Yves‐Rémi; Galuppo, Adrien; Ajouaou, Yousra; Decaestecker, Christine; Kassiotis, George; Moser, Muriel; Leo, Oberdan Journal: EMBO journal Issue: Volume 37:Number 3(2018) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗